Stanford Researchers Develop Noninvasive Urine Test for Bladder Cancer

Researchers at Stanford have created uRARE-seq, a new urine test that detects bladder cancer by analyzing RNA fragments instead of DNA. This noninvasive method could simplify diagnosis, differentiate cancer grades, track treatment efficacy, and predict immunotherapy response, potentially reducing the need for invasive procedures. The findings were published in Nature Medicine.